{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T22:28:55Z","timestamp":1794522535076,"version":"4.9.1"},"reference-count":23,"publisher":"Medical Association of Nippon Medical School","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nippon Med Sch"],"published-print":{"date-parts":[[2025,2,25]]},"DOI":"10.1272\/jnms.jnms.2025_92-114","type":"journal-article","created":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T22:13:35Z","timestamp":1741299215000},"page":"88-96","source":"Crossref","is-referenced-by-count":3,"title":["Effects of Biologics on Fibrosis-4 Index in Patients with Psoriasis"],"prefix":"10.1272","volume":"92","author":[{"given":"Takashi","family":"Morita","sequence":"first","affiliation":[{"name":"Department of Dermatology, Nippon Medical School Tama Nagayama Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susumu","family":"Ichiyama","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiko","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeko","family":"Ozaki","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taeang","family":"Arai","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Atsukawa","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhiko","family":"Iwakiri","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teppei","family":"Hagino","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Nippon Medical School Chiba Hokusoh Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiko","family":"Hoashi","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Kanda","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Nippon Medical School Chiba Hokusoh Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidehisa","family":"Saeki","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"21","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Kanda N, Hoashi T, Saeki H. Nutrition and psoriasis. Int J Mol Sci. 2020 Jul;21 (15):5405.","DOI":"10.3390\/ijms21155405"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Kanda N, Hoashi T, Saeki H. The defect in regulatory T cells in psoriasis and therapeutic approaches. J Clin Med. 2021 Aug;10 (17):3880.","DOI":"10.3390\/jcm10173880"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Rinella ME, Lazarus JV, Ratziu V, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2023 Dec;78 (6):1966-86.","DOI":"10.1097\/HEP.0000000000000520"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Neagoe CD, Farmazon AS, Amzolini AM, et al. The role of non-invasive scores in determining the liver fibrosis in NAFLD and psoriatic patients. Rom J Morphol Embryol. 2020 Apr-Jun;61 (2):503-11.","DOI":"10.47162\/RJME.61.2.20"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Prussick RB, Miele L. Nonalcoholic fatty liver disease in patients with psoriasis: A consequence of systemic inflammatory burden? Br J Dermatol. 2018 Jul;179 (1):16-29.","DOI":"10.1111\/bjd.16239"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Gisondi P, Targher G, Zoppini G, Girolomoni G. Non-alcoholic fatty liver disease in patients with chronic plaque psoriasis. J Hepatol. 2009 Oct;51 (4):758-64.","DOI":"10.1016\/j.jhep.2009.04.020"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Madanagobalane S, Anandan S. The increased prevalence of nonalcoholic liver disease in psoriatic patients: A study from South India. Australas J Dermatol. 2012 Aug;53 (3):190-7.","DOI":"10.1111\/j.1440-0960.2012.00905.x"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Abedini R, Salehi M, Lajevardi V, Beygi S. Patients with psoriasis are at a higher risk of developing nonalcoholic fatty liver disease. Clin Exp Dermatol. 2015 Oct;40 (7):722-7.","DOI":"10.1111\/ced.12672"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Saeki H, Mabuchi T, Asahina A, et al. English version of Japanese guidance for use of biologics for psoriasis (the 2022 version). J Dermatol. 2023 Feb;50 (2):e41-68.","DOI":"10.1111\/1346-8138.16691"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Sterling RK, Lissen E, Clumeck N, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology. 2006 Jun;43 (6):1317-25.","DOI":"10.1002\/hep.21178"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Shibata Y, Fukuda T, Nobeyama Y, Asahina A. Evaluation of nonalcoholic fatty liver disease in Japanese patients with psoriasis: Chest CT imaging for screening purposes. J Dermatol. 2022 Dec;49 (12):1263-7.","DOI":"10.1111\/1346-8138.16564"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Neagoe CD, Farmazon AS, Amzolini AM, et al. The role of non-invasive scores in determining the liver fibrosis in NAFLD and psoriatic patients. Rom J Morphol Embryol. 2020 Apr-Jun;61 (2):503-11.","DOI":"10.47162\/RJME.61.2.20"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Macia-Villa C, Morell-Hita JL, Revenga-Martinez M, Diaz-Miguel Perez C. HLA-Cw6 allele and biologic therapy are protective factors against liver fibrosis in psoriatic arthritis patients. Clin Exp Rheumatol. 2023 May;41 (5):1179-82.","DOI":"10.55563\/clinexprheumatol\/anuuqb"},{"key":"14","unstructured":"14. Akuta N. [Non-invasive test for the diagnosis of liver fibrosis in patients with nonalcoholic fatty liver disease, and follow-up strategy]. Clinical Gastroenterology. 2021 Jul;36 (7):755-61. Japanese."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Ichiyama S, Ito M, Ozaki S, et al. Real-world screening data for liver fibrosis in psoriasis patients treated with biologics. J Nippon Med Sch. 2024 Dec;91 (6):534-40.","DOI":"10.1272\/jnms.JNMS.2024_91-613"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Takamura S, Teraki Y, Katayama E, et al. Effects of interleukin-17 inhibitors on hepatic fibrosis index in patients with psoriasis and metabolic dysfunction-associated fatty liver disease: Directed acyclic graphs. Clin Mol Hepatol. 2022 Apr;28 (2):269-72.","DOI":"10.3350\/cmh.2022.0040"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Takeshima R, Kamata M, Suzuki S, et al. Interleukin-23 inhibitors decrease Fibrosis-4 index in psoriasis patients with elevated Fbrosis-4 but not interleukin-17 inhibitors. J Dermatol. 2024 Sep;51 (9):1216-24. doi: 10.1111\/1346-8138.17277","DOI":"10.1111\/1346-8138.17277"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Matsuda KM, Kotani H, Hisamoto T, et al. Dual blockade of interleukin-17A and interleukin-17F as a therapeutic strategy for liver fibrosis: Investigating the potential effect and mechanism of brodalumab. Cytokine. 2024 Jun;178:156587.","DOI":"10.1016\/j.cyto.2024.156587"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Lebwohl M, Merola JF, Strober B, et al. Bimekizumab safety in moderate to severe plaque psoriasis: Rates of hepatic events and changes in liver parameters over 2 years in randomized phase 3\/3b trials. J Am Acad Dermatol. 2024 Aug;91 (2):281-9.","DOI":"10.1016\/j.jaad.2024.03.041"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Ozaki S, Ichiyama S, Ito M, Hoashi T, Kanda N, Saeki H. Real-world blood examination screening data before initiation of biologics for psoriasis patients. J Dermatol. 2022 May;49 (5):534-8.","DOI":"10.1111\/1346-8138.16333"},{"key":"21","unstructured":"21. Yamazaki S. [Aha statistics and astonishing Excel<sup>\u00ae<\/sup> statistical processing]. Saitama: Igakutosho Shuppan; 2010. Japanese."},{"key":"22","unstructured":"22. Nakajima A, Ogawa Y, Imajo K, Yoneda M, Saito S. [How to identify high risk NAFLD patients]. Kanzo Clinical Update. 2019 Oct;5 (2):131-5. Japanese."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Maya Y, Fujita Y, Nakayama C, et al. Severe subcutaneous hematoma in a patient with psoriatic arthritis: Changes of platelet count in psoriatic patients with biologic agents. J Dermatol. 2017 Dec;44 (12):1385-8.","DOI":"10.1111\/1346-8138.13981"}],"container-title":["Journal of Nippon Medical School"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnms\/92\/1\/92_JNMS.2025_92-114\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T04:56:08Z","timestamp":1741409768000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnms\/92\/1\/92_JNMS.2025_92-114\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,25]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1272\/jnms.jnms.2025_92-114","relation":{},"ISSN":["1345-4676","1347-3409"],"issn-type":[{"value":"1345-4676","type":"print"},{"value":"1347-3409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,25]]},"article-number":"JNMS.2025_92-114"}}